Search contract descriptions, companies and agencies.
REGENERON OTHER TRANSACTION AUTHORITY (OTA) AWARD
Total Committed
$147M
Product or Service Description
Biomedical Advanced Development R&D
Total Potential Value
$366M
Contracting Agency
Effective Date
Sept. 21, 2017
Funding Department
DEPT OF HEALTH AND HUMAN SERVICES
Type
Cost sharing
Solicitation Procedure
Negotiated proposal/quote
Extent Competed
Full and open competition
Recent Contract Actions 
Contracts can have multiple “contract actions”: This is how agencies spend money for a specific purpose, adjust the amount committed or change the contract in a way that doesn’t affect the amount. That last scenario is usually indicated by a $0 action. If there is a contract action for a negative amount, it generally means the contract was adjusted or canceled.
| Vendor | Description | Signed | Reason for Change | Amount Committed |
|---|---|---|---|---|
| REGENERON PHARMACEUTICALS, INC. | ADDED A SUPPLEMENT FOR KEVZARA. THIS COVERS THE OVER-RECRUITMENT OF 1,470 PARTICIPANTS. | June 18, 2020 | Supplemental Agreement For Work Within Scope | $53,517,946 |
| REGENERON PHARMACEUTICALS, INC. | REGENERON OTHER TRANSACTION AUTHORITY (OTA) AWARD | March 21, 2020 | Change Order | $92,984,806 |
About this data
This data comes from the Federal Procurement Data System, which includes all contracts worth $10,000 or more. We look at all contracts that are tagged with the procurement code for COVID-19 or otherwise started in 2020 and contain “COVID-19” in the description. Department of Defense contracting data is subject to a 90-day delay before it appears in the data.